Charter must be a busy man, indeed. Too busy to make one of his websites functional or acknowledge that RXPC shareholders exist or update the USPTO Agent and Contact Information for the rejected patent.
He has a Tweet account but he has never sent a Tweet. Busy, busy, busy. Nobody even knows which continent he calls home.
I wonder if Radient will try to raise money the way GCDx and eWellness are trying to raise money -- GCDx on Fundable.com, eWellness on EquityNet:
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.